Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 13 Issue 10, October 2007

LINGO-1 is a member of a family of molecules known to inhibit axonal growth. In this issue, Wu and colleagues (p 1228) show that LINGO-1 inhibits myelination in an animal model of multiple sclerosis. The cover shows a cross section of myelinated axons in the central nervous system. Source: Corbis.

Editorial

  • What would you do if you could publish only 20 papers throughout your career?

    Editorial

    Advertisement

Top of page ⤴

News

  • After four years at the helm of Britain's Medical Research Council (MRC), which governs a £530-million research budget, Colin Blakemore is stepping down. As Nature Medicine went to press, a successor had not been formally announced. Here Blakemore talks about his tenure at the agency, the future of British medical research and the community's fears over the council's new 'translational' agenda, proposed by the government's 2006 Cooksey Review, which recommends shifting the focus to more applied research.

    • Michael Hopkin
    News
  • Timeline of events...a brief history of the important news stories this month

    News
  • Funding is tight. Grants are rejected. Research equipment is too expensive. And these are complaints heard in well-heeled laboratories in the US and UK. In the following pages, we present inspiring examples of scientists who, using materials as simple as litmus paper, bamboo and blenders, prove that science on a shoestring is possible—and sometimes even better than the alternative.

    • Paroma Basu
    News
  • Since the late 1980s, the San Francisco-based Sustainable Sciences Institute has made it its mission to train scientists in resource-poor countries and help them cobble together low-cost devices—to “give people the tools they need and let them run with them,” as its ebullient leader Eva Harris says. Among the institute's most famous inventions, for example, are a centrifuge made from a blender and a no-frills PCR method that uses homemade thermal cycling equipment and ceramic dust instead of silica for purifying the DNA. A 1997 MacArthur fellowship allowed Harris to expand the institute from an informal setup to a more official organization. Since then, with an annual budget of about $1 million that is coaxed from foundations and from individual donors, the institute has held more than 30 workshops, training mainly Latin American scientists in topics ranging from diagnostics to epidemiology to grant writing. The institute also gives out mini-grants to the most promising projects. Here Harris talks about the philosophy behind the institute's unique approach, its successes, its many ongoing projects and the eternal struggle for funding.

    • Emma Marris
    News
Top of page ⤴

Correspondence

Top of page ⤴

Book Review

Top of page ⤴

News & Views

  • Obesity and a diet rich in saturated fatty acids can lead to high lipid levels in the liver and insulin resistance. However, inhibition of a key enzyme that elongates long-chain saturated fatty acids can protect against insulin resistance in fatty livers, even with concurrent obesity (pages 1193–1202).

    • Clinton R Bruce
    • Mark A Febbraio
    News & Views
  • MicroRNAs contribute to HIV-1 latency in resting T cells. This finding could potentially be used in the development of therapies targeted to purge the latent reservoir in an effort to clear the body of virus (pages 1241–1247).

    • Yefei Han
    • Robert F Siliciano
    News & Views
  • The innate and adaptive immune systems act in concert to effectively combat infection while minimizing collater al damage caused by the host immune response. T cells of the adaptive immune system have now been shown to suppress overzealous early innate responses to infection that can lead to 'cytokine storm'–mediated death (pages 1248–1252).

    • Noah W Palm
    • Ruslan Medzhitov
    News & Views
  • Cytokine signaling from the tumor microenvironment can allow leukemia cells to survive targeted imatinib therapy, in the first report of a non-autonomous resistance mechanism.

    • Charles L Sawyers
    News & Views
Top of page ⤴

Commentary

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Technical Report

Top of page ⤴

Corrigendum

Top of page ⤴

Search

Quick links